About RBC Life Sciences (OTCMKTS:RBCL)
RBC Life Sciences, Inc. is engaged in the marketing of nutritional supplements and personal care products through subsidiaries in North America and Southeast Asia and through licensees in Russia/Eastern Europe. The Company's segments include Nutritional Products and Medical Products. Its Nutritional Products segment distributes products in over three categories: wellness products, fitness products and personal care products. Its Medical Products segment distributes wound care products. Nutritional Products are marketed under the RBC Life brand name. As of September 30, 2015, its Nutritional Products segment manufactured and distributed a line of over 100 nutritional supplements and personal care products, including herbs, vitamins and minerals, as well as natural skin, hair and body care products. As of September 30, 2015, it marketed a line of over 35 wound care products under the MPM Medical brand name through a subsidiary operating primarily in the United States.
Industry, Sector and Symbol:
- Market Cap: $0.00
- Outstanding Shares: 2,212,000
- 50 Day Moving Avg: $0.27
- 200 Day Moving Avg: $0.36
- 52 Week Range: $0.15 - $0.70
Sales & Book Value:
- Trailing P/E Ratio: N/A
- P/E Growth: 0.00
- Annual Revenue: $24.12 million
- Price / Sales: 0.02
- Book Value: $3.63 per share
- Price / Book: 0.07
- Average Volume: 248 shs.
- Beta: -0.54
Frequently Asked Questions for RBC Life Sciences (OTCMKTS:RBCL)
What is RBC Life Sciences' stock symbol?
RBC Life Sciences trades on the OTCMKTS under the ticker symbol "RBCL."
Who are some of RBC Life Sciences' key competitors?
Some companies that are related to RBC Life Sciences include Johnson & Johnson (JNJ), Roche Holding (RHHBY), Novartis AG (NVS), Pfizer (PFE), Merck & Co. (MRK), UnitedHealth Group (UNH), Sanofi SA (SNY), Medtronic plc. (MDT), Bayer AG (BAYRY), Amgen (AMGN), GlaxoSmithKline plc (GSK), AbbVie (ABBV), Novo Nordisk A/S (NVO), Celgene (CELG), Bristol-Myers Squibb Co (BMY), AstraZeneca plc (AZN), Gilead Sciences (GILD) and Eli Lilly and Co (LLY).
How do I buy RBC Life Sciences stock?
Shares of RBC Life Sciences can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of RBC Life Sciences stock cost?
One share of RBC Life Sciences stock can currently be purchased for approximately $0.27.
Consensus Ratings for RBC Life Sciences (OTCMKTS:RBCL) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.
|Ratings Breakdown: ||1 Sell Rating|
|Consensus Rating:||Sell (Score: 1.00)|
|Consensus Price Target: ||N/A|
Analysts' Ratings History for RBC Life Sciences (OTCMKTS:RBCL)
(Data available from 5/22/2015 forward)
|5/17/2017||ValuEngine||Downgrade||Hold -> Sell|
Earnings History for RBC Life Sciences (OTCMKTS:RBCL)
No earnings announcements for this company have been tracked by MarketBeat.com
Earnings Estimates for RBC Life Sciences (OTCMKTS:RBCL)
No earnings estimates for this company have been tracked by MarketBeat.com
Dividend History for RBC Life Sciences (OTCMKTS:RBCL)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for RBC Life Sciences (OTCMKTS:RBCL)
Insider Ownership Percentage: 45.80%Insider Trades by Quarter for RBC Life Sciences (OTCMKTS:RBCL)
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|6/16/2014||Clinton H Howard||CEO||Buy||5,000||$0.60||$3,000.00|| |
|6/2/2014||Clinton H Howard||CEO||Buy||3,100||$0.60||$1,860.00|| |
Headline Trends for RBC Life Sciences (OTCMKTS:RBCL)
Latest Headlines for RBC Life Sciences (OTCMKTS:RBCL)
RBC Life Sciences (RBCL) Chart for Monday, May, 22, 2017